These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32827918)

  • 1. Bavachinin inhibits cholesterol synthesis enzyme FDFT1 expression via AKT/mTOR/SREBP-2 pathway.
    Dong X; Zhu Y; Wang S; Luo Y; Lu S; Nan F; Sun G; Sun X
    Int Immunopharmacol; 2020 Nov; 88():106865. PubMed ID: 32827918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression.
    Weng ML; Chen WK; Chen XY; Lu H; Sun ZR; Yu Q; Sun PF; Xu YJ; Zhu MM; Jiang N; Zhang J; Zhang JP; Song YL; Ma D; Zhang XP; Miao CH
    Nat Commun; 2020 Apr; 11(1):1869. PubMed ID: 32313017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis.
    Harris IR; Farrell AM; Holleran WM; Jackson S; Grunfeld C; Elias PM; Feingold KR
    J Lipid Res; 1998 Feb; 39(2):412-22. PubMed ID: 9508001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP.
    Porstmann T; Griffiths B; Chung YL; Delpuech O; Griffiths JR; Downward J; Schulze A
    Oncogene; 2005 Sep; 24(43):6465-81. PubMed ID: 16007182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
    Flint OP; Masters BA; Gregg RE; Durham SK
    Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments.
    Ha NT; Lee CH
    Cells; 2020 Oct; 9(11):. PubMed ID: 33113804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ellagic acid ameliorates AKT-driven hepatic steatosis in mice by suppressing de novo lipogenesis via the AKT/SREBP-1/FASN pathway.
    Zhang C; Hu J; Sheng L; Yuan M; Wu Y; Chen L; Wang G; Qiu Z
    Food Funct; 2019 Jun; 10(6):3410-3420. PubMed ID: 31123744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
    Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
    J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA lncARSR promotes hepatic cholesterol biosynthesis via modulating Akt/SREBP-2/HMGCR pathway.
    Huang J; Chen S; Cai D; Bian D; Wang F
    Life Sci; 2018 Jun; 203():48-53. PubMed ID: 29678744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic effects of phytol and retinol on human glioblastoma cells are associated with modulation of cholesterol and fatty acid biosynthetic pathways.
    Facchini G; Ignarro RS; Rodrigues-Silva E; Vieira AS; Lopes-Cendes I; Castilho RF; Rogerio F
    J Neurooncol; 2018 Feb; 136(3):435-443. PubMed ID: 29159775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of nonstatin cholesterol lowering agents.
    Trapani L; Segatto M; Ascenzi P; Pallottini V
    IUBMB Life; 2011 Nov; 63(11):964-71. PubMed ID: 21990243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
    Ness GC; Zhao Z; Keller RK
    Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
    Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
    Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease.
    Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y
    Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia.
    Seiki S; Frishman WH
    Cardiol Rev; 2009; 17(2):70-6. PubMed ID: 19367148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
    Brusselmans K; Timmermans L; Van de Sande T; Van Veldhoven PP; Guan G; Shechter I; Claessens F; Verhoeven G; Swinnen JV
    J Biol Chem; 2007 Jun; 282(26):18777-85. PubMed ID: 17483544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and regulation of mammalian squalene synthase.
    Tansey TR; Shechter I
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):49-62. PubMed ID: 11111077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis.
    Zhang M; Chi X; Qu N; Wang C
    Biochem Biophys Res Commun; 2018 Apr; 499(1):66-70. PubMed ID: 29555473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.